Metadrena - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 301,438 | 311,176 | 260,118 | 39,513 | 32,842 | 31,894 | 34,859 | 52,560 |
| Profit before tax | -21,905 | -4,943 | 2,793 | 42,146 | 2,918 | 852 | 51 | 1,263 |
| Net profit | -21,905 | -4,943 | 2,371 | 42,146 | 1,906 | 724 | 43 | 1,061 |
| Equity | -38,849 | -43,792 | -41,421 | 725 | 2,631 | 3,355 | 3,398 | 4,459 |
| Liabilities | 117,227 | 85,177 | 49,991 | 5,366 | 4,824 | 4,350 | 2,126 | 30,050 |
| Non-current assets | 48,534 | 4,957 | 4,111 | 1,307 | 962 | 616 | 1,119 | 22,693 |
| Current assets | 29,736 | 36,239 | 4,371 | 4,784 | 6,384 | 6,940 | 4,240 | 11,172 |
| Total assets | 78,270 | 41,196 | 8,482 | 6,091 | 7,346 | 7,556 | 5,359 | 33,865 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 12,130 | 13,057 | 14,228 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -13.8% | +3.2% | -16.4% | -84.8% | -16.9% | -2.9% | +9.3% | +50.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -28.0% | -12.0% | 28.0% | 691.9% | 25.9% | 9.6% | 0.8% | 3.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | 5813.2% | 72.4% | 21.6% | 1.3% | 23.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -7.3% | -1.6% | 0.9% | 106.7% | 5.8% | 2.3% | 0.1% | 2.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -7.3% | -1.6% | 1.1% | 106.7% | 8.9% | 2.7% | 0.1% | 2.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 7.4 | 1.8 | 1.3 | 0.6 | 6.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 150,719 | 155,588 | 130,059 | 39,513 | 32,842 | 31,894 | 34,859 | 42,048 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Metadrena - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 2.32 |
| 2026-07-28 | 2026-08-11 | 2.32 |
| 2026-07-23 | 2026-07-26 | 2.32 |
| 2026-05-17 | 2026-05-17 | 2864.11 |
Metadrena - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-15 | 2026-05-18 | 960.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Metadrena, UAB, a Private Limited Liability Company (code 303173761), operates in wholesale of agricultural machinery, equipment and supplies. In 2025, the company increased revenue to €52.6K, up 50.8% year on year and 64.8% over two years. Net profit improved to €1.1K from €43 in 2024 and €724 in 2023, while the profit margin remained modest at 2.0%. The three-year pattern shows rising turnover after a weak 2024 result, with profitability recovering in 2025 after a period of very thin earnings. The balance sheet expanded sharply in 2025: total assets reached €33.9K, compared with €5.4K in 2024 and €7.6K in 2023. Equity rose to €4.5K, while liabilities increased to €30.1K, lifting leverage materially. Long-term assets also grew to €22.7K, indicating a larger asset base than in prior years. Latest ratios show ROE of 23.8%, ROA of 3.1%, debt-to-equity of 6.74, and asset turnover of 1.55x. Revenue per employee was €52.6K and profit per employee €1.1K in 2025.